Menu Back toSession 2: Lessons Learned and Best Practices for Decentralized Clinical Trials: Can We Plan and Execute More Patient-Friendly Clinical Trials?

Digital Technology in Clinical Trials Conference

Digital Technology in Clinical Trials Conference is now fully virtual. Join us from the comfort of your own space!

Session 2: Lessons Learned and Best Practices for Decentralized Clinical Trials: Can We Plan and Execute More Patient-Friendly Clinical Trials?

Session Chair(s)

Megan Doyle, JD, MPH

Megan Doyle, JD, MPH

  • Global Policy Lead, Digital Health, Diagnostics, Oncology
  • Amgen, United States
This session will focus on what we’ve learned thus far in trying to implement decentralized techniques in clinical trials. Specifically, speakers will share lessons learned and best practices observed to date. Additionally, based on these lessons learned, we will discuss remaining challenges and paths forward for addressing those challenges.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Articulate best practices in planning and executing decentralized trials
  • Understand some lessons learned related to using decentralized techniques in clinical trials to date
  • Assess the challenges that remain for broad scale decentralized trial adoption

Speaker(s)

Scott Askin, MSc

Speakers

Scott Askin, MSc

  • Global Program Regulatory Director
  • Novartis Pharma AG, Switzerland
Abba Elizabeth Theogaraj, PhD

Speaker

Abba Elizabeth Theogaraj, PhD

  • Regulatory Senior Group Director
  • Roche, Switzerland
Reem Yunis, PhD

Speaker

Reem Yunis, PhD

  • Vice President, Digital Transformation Strategy
  • Medable, United States
Sarah Krug, MS

Speaker

Sarah Krug, MS

  • Executive Director
  • CANCER101, United States

Contact us

Registration Questions?

Send Email
+1.215.442.6100

Preconference Short Course

Digital Health - From Concept to Implementation

Discover DIA’s Live In-Person Events

Digital Technology in Clinical Trials Conference Resource Kit